Sintx Technologies, Inc. (SINT) is a Medical - Devices company in the Healthcare sector, currently trading at $2.80. It has a SharesGrow Score of 37/100, indicating a weak investment profile with 1 out of 7 criteria passed.
Valuation: SINT trades at a trailing Price-to-Earnings (P/E) of -0.4 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.01.
Financials: revenue is $1M, +94.1%/yr average growth. Net income is $17M (loss), growing at -12.8%/yr. Net profit margin is -1678.1% (negative). Gross margin is -19.7% (-75.6 pp trend).
Balance sheet: total debt is $3M against $3M equity (Debt-to-Equity (D/E) ratio 1.11, moderate). Current ratio is 1.51 (strong liquidity). Debt-to-assets is 34.1%. Total assets: $10M.
Analyst outlook: 1 / 2 analysts rate SINT as buy (50%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 58/100 (Partial), Past 0/100 (Fail), Health 50/100 (Partial), Moat 0/100 (Fail), Future 40/100 (Partial), Income 10/100 (Fail).
